These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16014861)

  • 1. Plasmodium falciparum genotyping by microsatellites as a method to distinguish between recrudescent and new infections.
    Nyachieo A; VAN Overmeir C; Laurent T; Dujardin JC; D'Alessandro U
    Am J Trop Med Hyg; 2005 Jul; 73(1):210-3. PubMed ID: 16014861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
    Cattamanchi A; Kyabayinze D; Hubbard A; Rosenthal PJ; Dorsey G
    Am J Trop Med Hyg; 2003 Feb; 68(2):133-9. PubMed ID: 12641400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria.
    Happi CT; Gbotosho GO; Sowunmi A; Falade CO; Akinboye DO; Gerena L; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Am J Trop Med Hyg; 2004 Jan; 70(1):20-6. PubMed ID: 14971693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy.
    Slater M; Kiggundu M; Dokomajilar C; Kamya MR; Bakyaita N; Talisuna A; Rosenthal PJ; Dorsey G
    Am J Trop Med Hyg; 2005 Aug; 73(2):256-62. PubMed ID: 16103584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment.
    Mugittu K; Priotto G; Guthmann JP; Kiguli J; Adjuik M; Snounou G; Beck HP; Mshinda H; Olliaro PL; Taylor WR
    Trop Med Int Health; 2007 Feb; 12(2):219-23. PubMed ID: 17300628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness.
    Mugittu K; Adjuik M; Snounou G; Ntoumi F; Taylor W; Mshinda H; Olliaro P; Beck HP
    Trop Med Int Health; 2006 Sep; 11(9):1350-9. PubMed ID: 16930256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of microsatellite and antigen-coding loci for differentiating recrudescing Plasmodium falciparum infections from reinfections in Kenya.
    Mwangi JM; Omar SA; Ranford-Cartwright LC
    Int J Parasitol; 2006 Mar; 36(3):329-36. PubMed ID: 16442537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distinguishing Plasmodium falciparum populations for clinical research].
    Eboumbou Moukoko EC; Bogreau H; Briolant S; Pradines B; Rogier C
    Med Trop (Mars); 2009 Dec; 69(6):613-7. PubMed ID: 20099682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials.
    Koepfli C; Mueller I; Marfurt J; Goroti M; Sie A; Oa O; Genton B; Beck HP; Felger I
    J Infect Dis; 2009 Apr; 199(7):1074-80. PubMed ID: 19275476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Bolaji OM; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Am J Trop Med Hyg; 2006 Jul; 75(1):155-61. PubMed ID: 16837724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic relatedness of Plasmodium falciparum isolates and the origin of allelic diversity at the merozoite surface protein-1 (MSP-1) locus in Brazil and Vietnam.
    Hoffmann EH; Ribolla PE; Ferreira MU
    Malar J; 2003 Jul; 2():24. PubMed ID: 12941155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited advantage of multiple consecutive samples for genotyping Plasmodium falciparum populations during the first days of treatment.
    Färnert A; Björkman A
    Am J Trop Med Hyg; 2005 Jul; 73(1):204-6. PubMed ID: 16014859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in East Timor.
    Burns M; Baker J; Auliff AM; Gatton ML; Edstein MD; Cheng Q
    Am J Trop Med Hyg; 2006 Mar; 74(3):361-6. PubMed ID: 16525092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials.
    Greenhouse B; Dokomajilar C; Hubbard A; Rosenthal PJ; Dorsey G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3096-103. PubMed ID: 17591848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections.
    Greenhouse B; Myrick A; Dokomajilar C; Woo JM; Carlson EJ; Rosenthal PJ; Dorsey G
    Am J Trop Med Hyg; 2006 Nov; 75(5):836-42. PubMed ID: 17123974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
    Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum multiple infections, disease severity and host characteristics in malaria affected travellers returning from Africa.
    Nicastri E; Paglia MG; Severini C; Ghirga P; Bevilacqua N; Narciso P
    Travel Med Infect Dis; 2008 Jul; 6(4):205-9. PubMed ID: 18571110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing Plasmodium falciparum treatment failures from reinfections by restrictions fragment length polymorphism and polymerase chain reaction genotyping.
    Ohrt C; Mirabelli-Primdahl L; Karnasuta C; Chantakulkij S; Kain KC
    Am J Trop Med Hyg; 1997 Oct; 57(4):430-7. PubMed ID: 9347959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of msp genotyping and a 24 SNP molecular assay for differentiating Plasmodium falciparum recrudescence from reinfection.
    Fulakeza J; McNitt S; Vareta J; Saidi A; Mvula G; Taylor T; Mathanga DP; Small DS; Skarbinski J; Gutman JR; Seydel K
    Malar J; 2019 Mar; 18(1):84. PubMed ID: 30885193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
    Ojurongbe O; Ogungbamigbe TO; Fagbenro-Beyioku AF; Fendel R; Kremsner PG; Kun JF
    Malar J; 2007 Apr; 6():41. PubMed ID: 17428334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.